Revised forecast
Fiscal year ending September 2026 · Interim consolidated accounting period (1 October 2025 to 31 March 2026)Previous forecast published 13 November 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Revenue and each profit item exceeded the previous forecast because (1) a large project for drugstores scheduled for delivery in the third-quarter accounting period was brought forward to the second-quarter accounting period, (2) promotional initiatives targeting SMEs (small and medium-sized merchants) were successful and drove steady merchant acquisition, and (3) recurring revenue increased steadily as the number of payment transactions and GMV (gross payment volume) expanded, among other factors.
| Item | Details |
|---|---|
| Net Sales | ¥8,639 million → ¥10,515 million（+21.7%） |
| Operating profit | ¥1,388 million → ¥1,559 million（+12.4%） |
| Profit attributable to owners of the parent | ¥914 million (interim profit) → ¥1,049 million (interim profit)（+14.9%） |
| Net income per share | 110.72 yen (basic interim earnings per share) → 127.18 yen (basic interim earnings per share) |
| Fiscal Period Covered | Fiscal year ending September 2026 |
| Period Covered | Interim consolidated accounting period (1 October 2025 to 31 March 2026) |
| Publication date of previous forecast | 13 November 2025 |
| Previous-period results | Interim period of the fiscal year ended September 2025: revenue of ¥9,046 million, operating profit of ¥1,382 million, profit before tax of ¥1,379 million, interim profit of ¥1,021 million, interim profit attributable to owners of the parent of ¥1,034 million, and basic interim earnings per share of ¥125.09 |
| Reason for the revision | Revenue and each profit item exceeded the previous forecast because (1) a large project for drugstores scheduled for delivery in the third-quarter accounting period was brought forward to the second-quarter accounting period, (2) promotional initiatives targeting SMEs (small and medium-sized merchants) were successful and drove steady merchant acquisition, and (3) recurring revenue increased steadily as the number of payment transactions and GMV (gross payment volume) expanded, among other factors. |
| Dividend forecast revision | No change (unchanged from the forecast announced on 13 November 2025) |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.A large project for drugstores scheduled for the third quarter was brought forward to the second quarter, promotions targeting SMEs were successful and drove steady merchant acquisition, and recurring revenue increased as the number of payment transactions and GMV expanded.